A report on the experiences of 13 patients found that the drug had no benefit for some and that some who benefited said the ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating symptoms. Research shows extended Paxlovid treatment could help restore ...

These companies headline a $1.4 trillion industry, have staying power, and will pay you well to hold their stock.

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Pfizer CEO highlights savings, leadership changes, and acquisition-driven growth amid significant revenue loss challenges ...

A detailed examination of how patients respond to the drug at various times and doses provides greater context to a recent ...

Wedmont Private Capital lessened its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 17.7% in the fourth ...

Brookstone Capital Management trimmed its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 11.9% in the fourth ...

At the JPM conference, Pfizer CEO Albert Bourla projected optimism, saying the market was overlooking the pharma company's ...

Four in 10 Minnesotans who contracted COVID-19 reported in a new state survey that they struggled with lingering health ...

Federal science agencies have renewed and increased funding for a world-renowned digital archive of protein structures housed ...